Worth reading
48Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
218000
SharesWording
Conditional
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights as stock options
Who receives how much
218,000 common shares of the Company (2,180 stock acquisition rights, with 100 shares per stock acquisition right)
2 directors of the Company300
6 executive vice presidents and executive officers of the Company850
50 directors, executive officers and other employees of the Company's consolidated subsidiaries1,030
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
The stock acquisition rights will be issued at no charge. The exercise price per share has not yet been determined.
Terms of the stock acquisition rights
Exercise price
The initial exercise price has not yet been determined. The terms provide for adjustments in the event of a stock split or consolidation, an issuance of new shares or disposal of treasury shares at a price below market value, a merger or other similar event. The lower limit for adjustments is Not disclosed.
Exercise period
From 13 June 2028 to 12 June 2033
Number of Stock Acquisition Rights
Total number to be issued: 2,180. Number remaining unexercised: Not disclosed
Reason for acquisition without consideration
The Company may acquire the stock acquisition rights at no charge if a holder ceases to satisfy the exercise conditions or otherwise becomes unable to exercise the rights, or if an agreement or proposal for a merger or other transaction in which the Company becomes the disappearing company is approved at a general meeting of shareholders.
Categories and Number of Persons Covered
Category Directors of the company / Number of Employees 2 / Number of allocated shares 30,000 shares (300 stock acquisition rights), Category Executive vice presidents and executive officers of the Company / Number of Employees 6 / Number of allocated shares 85,000 shares (850 stock acquisition rights), Category Directors, executive officers and other employees of the Company's consolidated subsidiaries / Number of Employees 50 / Number of allocated shares 103,000 shares (1,030 stock acquisition rights)
Payment date
No payment is required for the stock acquisition rights.
Basis for determining the amount to be paid
The exercise price will be the average closing price for regular trading of the Company's common shares on the Tokyo Stock Exchange on each trading day in the month preceding the month in which the allotment date falls, multiplied by 1.03. However, if this amount is below the closing price on the allotment date, the closing price on the allotment date will apply. The specific amount has not yet been determined.
Procedures under the Corporate Code of Conduct
Approved at the 53rd Annual General Meeting of Shareholders held on 27 June 2025. The specific details of the issuance were determined at a meeting of the Board of Directors held on 5 June 2026.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights as stock options |
| Number of shares to be issued or disposed of | 218,000 common shares of the Company (2,180 stock acquisition rights, with 100 shares per stock acquisition right) |
| Issue price and disposal price | The stock acquisition rights will be issued at no charge. The exercise price per share has not yet been determined. |
| Payment date | No payment is required for the stock acquisition rights. |
| Intended allottee | Category 2 directors of the Company / Number of units 300, Category 6 executive vice presidents and executive officers of the Company / Number of units 850, Category 50 directors, executive officers and other employees of the Company's consolidated subsidiaries / Number of units 1,030 |
| Basis for determining the amount to be paid | The exercise price will be the average closing price for regular trading of the Company's common shares on the Tokyo Stock Exchange on each trading day in the month preceding the month in which the allotment date falls, multiplied by 1.03. However, if this amount is below the closing price on the allotment date, the closing price on the allotment date will apply. The specific amount has not yet been determined. |
| Exercise price | The initial exercise price has not yet been determined. The terms provide for adjustments in the event of a stock split or consolidation, an issuance of new shares or disposal of treasury shares at a price below market value, a merger or other similar event. The lower limit for adjustments is Not disclosed. |
| Exercise period | From 13 June 2028 to 12 June 2033 |
| Number of Stock Acquisition Rights | Total number to be issued: 2,180. Number remaining unexercised: Not disclosed |
| Reason for acquisition without consideration | The Company may acquire the stock acquisition rights at no charge if a holder ceases to satisfy the exercise conditions or otherwise becomes unable to exercise the rights, or if an agreement or proposal for a merger or other transaction in which the Company becomes the disappearing company is approved at a general meeting of shareholders. |
| Categories and Number of Persons Covered | Category Directors of the company / Number of Employees 2 / Number of allocated shares 30,000 shares (300 stock acquisition rights), Category Executive vice presidents and executive officers of the Company / Number of Employees 6 / Number of allocated shares 85,000 shares (850 stock acquisition rights), Category Directors, executive officers and other employees of the Company's consolidated subsidiaries / Number of Employees 50 / Number of allocated shares 103,000 shares (1,030 stock acquisition rights) |
| Procedures under the Corporate Code of Conduct | Approved at the 53rd Annual General Meeting of Shareholders held on 27 June 2025. The specific details of the issuance were determined at a meeting of the Board of Directors held on 5 June 2026. |
Items this document does not state (16)
Total issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To provide directors, executive officers and employees of the Company and its consolidated subsidiaries with an incentive to improve the performance of the Company Group, increase corporate value and promote management with an emphasis on shareholders.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.